JMP Securities analyst Constantine Davides lowered the firm’s price target on AMN Healthcare (AMN) to $57 from $66 and keeps an Outperform rating on the shares. The firm continues to look for indications that the healthcare staffing industry has the potential to stabilize in 2025 following its COVID-related peak in early 2022, the analyst tells investors in a research note. JMP says it is focusing its attention on AMN’s international nursing business and organic locum tenens trends.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AMN: